Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
28 févr. 2024 06h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,...
Integra LifeSciences Announces Leadership Transition Plan
28 févr. 2024 06h00 HE
|
Integra LifeSciences Holdings Corporation
Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings...
Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
07 févr. 2024 09h15 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year...
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
05 janv. 2024 16h30 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president...
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
13 déc. 2023 06h15 HE
|
Integra LifeSciences Holdings Corporation
The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the...
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors
12 déc. 2023 12h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Jeff Graves, Ph.D.,...
Integra LifeSciences Reports Third Quarter 2023 Financial Results
25 oct. 2023 06h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences to Host Third Quarter 2023 Financial Results Conference Call on October 25, 2023
04 oct. 2023 08h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2023 financial...
Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
01 sept. 2023 17h04 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief...
Integra LifeSciences Reports Second Quarter 2023 Financial Results
26 juil. 2023 18h30 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...